Company intelligence / Profile preview
AN2 Therapeutics, Inc.
Menlo Park, California, United Statesan2therapeutics.com ↗
- Ownership
- Public · ANTX
- Employees
- ~50
- Development stage
- Other
01
Overview
The company's lead candidate epetraborole for treatment-refractory MAC lung disease did not meet its primary endpoint in the Phase 3 portion of the EBO-301 study. The Phase 2 portion had shown nominal statistical significance on two patient-reported outcome measures. The company is now focusing on other pipeline programs including treatments for Chagas disease and melioidosis, as well as developing oncology candidates.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculesboron-based compounds
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Bill and Melinda Gates FoundationWellcome TrustMedicines for Malaria VentureDrugs for Neglected Disease initiative (DNDi)GlaxoSmithKline (GSK)Eli Lilly & Company
04
Financials
- Market cap
- $149.2M
- Total revenue
- $0
- Enterprise value
- $70.9M
Beyond the preview
Go deeper on AN2 Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AN2 Therapeutics, Inc..